The patent eligibility of claims involving the use of machine learning (ML) was recently considered by the US Court of Appeals for the Federal Circuit (CAFC) in Recentive Analytics, Inc. v. Fox Corp., ...
Discover the future of health coverage. Explore 4 modern digital solutions for 24/7 policy management, real-time claim ...
“On appeal, the CAFC agreed that ‘the patents are directed to the abstract idea of using a generic machine learning technique in a particular environment, with no inventive concept’.” The U.S. Supreme ...
Safeguarding Insurance Data through Privacy-Aware Machine Learning Insights from Keerthi Amistapuram
In the evolving digital landscape of insurance, the convergence of artificial intelligence and data governance has opened transformative opportunities and profound responsibilities. At the center of ...
“[T]he only thing the claims disclose about the use of machine learning is that machine learning is used in a new environment.” – CAFC The U.S. Court of Appeals for the Federal Circuit (CAFC) on ...
The latest release lets carriers, TPAs, and MGAs onboard new document types in minutes, letting AI Agents read the full ...
Emergence of AI has transformed mundane processes, delivery TATs and customer service across different industries. The ...
Optum is building out it claims management platform Real with new provider-focused capabilities built in partnership with Microsoft. By bringing together Optum's existing healthcare and AI experience ...
2025 FEB 19 (NewsRx) -- By a News Reporter-Staff News Editor at Health Policy and Law Daily-- Investigators publish new report on Machine Learning. According to news reporting originating in ...
Before Dyk, Prost, and Goldberg. Appeal from the United States District Court for the District of Delaware. Summary: The Federal Circuit found that claims applying established methods of machine ...
The global insurance sector has seen an 87% year-on-year increase in artificial intelligence deployments, according to research by AI intelligence and analytics Evident. And as we all look around for ...
Impact of response to gemcitabine-based neoadjuvant therapy on the outcomes of gemcitabine plus nab-paclitaxel after recurrence in pancreatic cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results